PainAid® BRF Back Relief Formula Tablets - Zee Medical

MSDS: 121MATERIAL SAFETY DATA SHEET REV. DATE: 2/12PAGE 1 OF 2Section I - PRODUCT IDENTIFICATIONZEE MEDICAL, INC.TRADE NAME: PainAid® BRF Back Relief Formula Tablets22 Corporate Park #1405, 1406, 1504Irvine, CA 92606800/841-8417Emergency Phone No. (CHEMTREC): 800/424-9300Section II - HAZARDOUS INGREDIENTSCAS PEL, TLV,INGREDIENT % NUMBER OSHA (mg/M 3 ) ACGIH (mg/M 3 )Acetaminophen 35-43 103-90-2 N/E N/EMagnesium Salicylate 28-35 18917-89-0 N/E 5Cornstarch < 5 9005-25-8 10 10Amorphous Silica < 5 7631-86-9 6 10Other NonhazardousIngredients < 5 N/A N/E N/ENOTE: This product has been formulated for internal use and is regulated by the FDA as a drug product. Under normalconditions of use, this product is not a hazardous material as defined by the OSHA Hazard Communication Standard (29CFR 1910.1200). Information provided concerning ingredients is for user's reference.Section III - PHYSICAL DATABoiling Point: N/AVapor Pressure: (mm Hg): N/AVapor Density: N/ASpecific Gravity: N/AMelting Point: N/AEvaporation Rate: N/ASolubility In Water: Nearly completeAppearance and Odor: Round, bi-layered white and yellow tablet (embossed “ZEE” & “BRF”), no odor.Section IV - FIRE AND EXPLOSION HAZARD DATAFlash Point: N/AExtinguishing Media: N/ASpecial Fire Fighting Procedures: NoneUnusual Fire and Explosion Hazards: NoneNFPA Hazard Rating: Health: 1 Flammability: 0 Reactivity: 0 Special: N/AHMIS Hazard Rating: Health: 1 Flammability: 0 Reactivity: 0Hazard Index: 4=Severe, 3=Serious, 2=Moderate, 1=Slight, 0=Minimal

MSDS: 121MATERIAL SAFETY DATA SHEET REV. DATE: 2/12PAGE 2 OF 2Section V - HEALTH HAZARD DATAPrimary Routes of Entry: Eye Contact, IngestionHealth Hazards: Eye contact may cause irritation and redness of the eyes. Ingestion of large quantities may causenausea, vomiting, ringing in ears, disorientation, cardiac arrhythmia, coma, and respiratory failure.Carcinogenicity: NTP: NO IARC: NO OSHA: NOReproductive Toxicity (Proposition 65 Warning): This product contains salicylates, which are known to the State ofCalifornia to cause birth defects or other reproductive harm. It is especially important not to use salicylates during thelast three months of pregnancy unless specifically directed to do so by a doctor because it may cause problems in theunborn child or complications during delivery.Emergency First Aid Procedures: Eye Contact: flush immediately with large amounts of water. If redness or irritationpersists, contact a physician. Ingestion: In case of accidental overdose, contact a physician or poison control centerimmediately.Section VI - REACTIVITY DATAStability: Stable Incompatibilities: NoneHazardous Decomposition Products: NoneHazardous Polymerization: Will not occurSection VII - SPILL AND DISPOSAL PROCEDURESSpill: Sweep up and transfer to a suitable waste disposal container.Disposal: Dispose of in accordance with local, state and federal regulations.Section VIII - SAFE HANDLING AND USE INFORMATIONRespiratory Protection: In processing tablets, if dust levels exceeding the TLV or PEL are encountered, use a NIOSHapproved particulate respirator meeting 42 CFR 84 requirements.Ventilation: General mechanical.Protective Equipment: Use eye protection as necessary to prevent excessive contact.Section IX - SPECIAL PRECAUTIONSNoneN/A = Not applicableN/E = Not established